Relmada Therapeutics RLMD
NASDAQ RLMD
$3.73 -0.06 (-1.58%)
At close: Sep 29, 2026 · 4:00 PM EDT

Relmada Therapeutics (RLMD) Total Current Liabilities (2012 - 2026)

Updated

Relmada Therapeutics' Total Current Liabilities was $7.42 million in Q2 2026, up 44.5% from $5.13 million a year earlier but down 42.4% from the prior quarter.

Analysis

Relmada Therapeutics (RLMD) Total Current Liabilities (2012 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at Relmada Therapeutics came in at $6.43 million, down 37.5% from FY2024.

  • Total Current Liabilities has now declined for four consecutive years, with a five-year compound annual growth rate of -12.6% (FY2020 to FY2025).
  • In earlier years, Total Current Liabilities was $10.29 million in FY2024 (-15.6%), $12.19 million in FY2023 (-2.2%), $12.47 million in FY2022 (-17.2%) and $15.06 million in FY2021 (+19.5%).
  • Quarterly Total Current Liabilities has moved between $5.13 million (Q2 2025) and $20.78 million (Q3 2022) over five years.
  • Compared with a year earlier, Total Current Liabilities was higher in two of the last eight quarters, with an average decline of 0.7%.
  • The best year-over-year quarter for Total Current Liabilities over five years was Q3 2021 (growth of 438.4%); the worst was Q3 2023 (a decline of 59.5%).
  • Per Business Quant data, RLMD's Total Current Liabilities in the three quarters before Q2 2026 was $12.89 million (Q1 2026), $6.43 million (Q4 2025) and $5.19 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Relmada Therapeutics 404.28 Mn 404.28 Mn - 7.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.42 Mn
Mar 31, 2026 12.89 Mn
Dec 31, 2025 6.43 Mn
Sep 30, 2025 5.19 Mn
Jun 30, 2025 5.13 Mn
Mar 31, 2025 5.23 Mn
Dec 31, 2024 10.29 Mn
Sep 30, 2024 8.09 Mn
Jun 30, 2024 9.54 Mn
Mar 31, 2024 12.36 Mn
Dec 31, 2023 12.19 Mn
Sep 30, 2023 8.42 Mn
Jun 30, 2023 10.70 Mn
Mar 31, 2023 10.10 Mn
Dec 31, 2022 12.47 Mn
Sep 30, 2022 20.78 Mn
Jun 30, 2022 18.92 Mn
Mar 31, 2022 15.41 Mn
Dec 31, 2021 15.06 Mn
Sep 30, 2021 18.25 Mn
API Access

Relmada Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=RLMD&period=max&api_key=YOUR_API_KEY